41 studies found for:    Open Studies | "Hair Diseases"
Show Display Options
Rank Status Study
1 Unknown  The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Condition: Female Pattern Alopecia
Interventions: Drug: 15 mg Chelate zinc supplement;   Drug: Placebo drug supplement
2 Unknown  Stem Cell Educator Therapy in Alopecia Areata
Condition: Alopecia Areata
Intervention: Device: Stem Cell Educator
3 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
4 Recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: CB-03-01 solution;   Drug: Minoxidil Solution 5%;   Drug: Placebo solution
5 Recruiting The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
Condition: ALOPECIA AREATA
Intervention: Drug: Methotrexate
6 Unknown  Hair Regrowth After Bicoronal Incision
Condition: Alopecia
Interventions: Procedure: Straight Incision;   Procedure: Bevelled Incision
7 Unknown  Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
Condition: Alopecia Areata
Interventions: Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
8 Unknown  Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
Conditions: Impetigo;   Folliculitis;   Secondarily Infected Eczema;   Minor Soft Tissue Infections
Intervention: Drug: Retapamulin (Altabax)
9 Unknown  Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
10 Recruiting Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Conditions: Menkes Disease;   Occipital Horn Syndrome;   Unexplained Copper Deficiency
Intervention: Drug: Copper Histidine
11 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
12 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
13 Unknown  The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
14 Unknown  Enhanced Safety Laser Hair Removal System
Conditions: Hirsutism;   Hypertrichosis
Intervention: Device: Peterio
15 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Conditions: Post Radiation/Chemotherapy Alopecia Presents With Hair Thinning.;   Post-burn Alopecia Presents With Hair Thinning.;   Cicatricial Alopecia Presents With Hair Thinning.;   Androgenetic Alopecia Presents With Hair Thinning;   Alopecia Due to Traumatic Injuries Presents With Hair Thinning.;   Alopecia Due to Skin Disease Presents With Hair Thinning.
Intervention: Device: Anchoring system
16 Recruiting 7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream
Conditions: Tattoo;   Acne Keloidalis Nuchae
Interventions: Drug: 2,5% lidocaine / 2,5% prilocaine cream;   Drug: 7% lidocaine / 7% tetracaine cream;   Device: Neodymium-doped yttrium aluminium garnet (Nd:Yag) laser;   Device: Q-switched nd Yag laser
17 Unknown  Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition: Alopecia
Interventions: Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel
18 Recruiting An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Condition: Alopecia Areata
Intervention: Drug: Tofacitinib
19 Unknown  Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
20 Recruiting Effect of PRP on the Therapy for Hair Growth
Condition: Hair Loss/Baldness
Intervention: Other: hair loss, baldness (patient's own platelet-rich plasma)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years